Centenial Celebration

Transaction Search Form: please type in any of the fields below.

Date: November 22, 2024 Fri

Time: 12:15 pm

Results for illicit drug markets (europe)

1 results found

Author: Trautmann, Franz

Title: Further Insights into Aspects of the EU Illicit Drugs Market: Summaries and Key Findings

Summary: • Our estimates for the EU cannabis market suggest a range of approximately €7 billion to €10 billion for 2010. These estimates are likely low as they do not account for the “consumption gap” (see below) that is created when data from general population surveys are used to measure substance use. Prior estimates of the EU cannabis market ranged from €15-35 billion. • This difference arises from two key findings of this study: o Cannabis users who use more frequently also smoke more each time they use. This is true across the seven countries studied. o Occasional users are more likely to share than are frequent users; that still further reduces the amount they consume at each session. o This picture also seems to apply to amphetamine, ecstasy and cocaine use. • Prior estimates multiplied the number of users by the average number of sessions per user and the average amount per session; this will lead to overestimates of the quantity consumed because, for example infrequent users are the vast majority of all users and they use much less per session as the result of sharing. • Our study also shows that intensive users are a small to modest fraction of cannabis users (between 5% and 25%), but are responsible for the bulk (between 55% and 77%) of the total amount of cannabis annually consumed in all countries. Infrequent users of cannabis, using less than once per month, form the largest group of past year cannabis users but account for 2 percent or less of the quantity consumed. • Another important finding is that users stating that they used in the past month and specifying the quantity used in the past month do not consume (the same amounts) each month. Multiplying their consumption by twelve to obtain an annual estimate may result in an overestimation. There are also other factors which might have led to earlier overestimations of cannabis consumption. One might be overstating the share of ‘high consumption users’ among past year. Finally, earlier studies have used higher estimates of amounts of cannabis used per unit compared to those we found in our study. • Substantial prior research finds that opioid substitution treatment (OST) such as methadone maintenance treatment (MMT) contributes substantially to a reduction of drug use related harm and to better health. Research shows that OST reduces the frequency and intensity of illicit heroin use among treatment clients. Drawing from a wider lower and upper bound range, the study calculates that the amount of pure illicit heroin consumption averted per Problem Heroin User retained in MMT each month ranges from a conservative estimate of 1.26 grams to a high estimate of 3.09 grams. This compares with estimates for the amount of pure heroin consumed when not engaged in MMT, which ranged from 1.79 to 4.5 grams. At an individual level, changes on this scale are equivalent to a 70 per cent reduction in the amount of pure heroin consumed while retained in MMT. • Extrapolating these estimates across the four case study Member States considered, we conclude that retention in MMT may reduce total pure heroin consumption by around 30 per cent. Assuming 221,452 Problem Heroin Users from a wider population of 505,173 were in receipt of MMT across these four Member States, total monthly consumption of pure heroin is estimated to have reduced by between 0.28 and 0.69 metric tons, from an estimated total of between 0.9 and 2.3 metric tons consumed. • Enforcing laws against the production and distribution of cannabis dramatically inflate their costs. The increase is largely driven by producers and traffickers requiring compensation for their risk of arrest, incarceration, seizure, and violent injury as well as by the inefficiencies associated with having to operate covertly. • Drug markets to some extent follow the same laws of economics of licit markets, as attested by our Delphi survey of European drug experts about key trends of the illicit drugs market and policy responses in the EU. The majority of experts stress the analogy of the illicit drugs market with other (licit) markets. For example, it is important to maintain working relations with suppliers and employees. A study of 33 failed transactions in the Dutch cocaine smuggling trade found that the smuggler mostly tried to understand what went wrong and work out a reasonable way of arranging compensation. However about 40% did involve either violence or its threat; how that affects behaviour within the market remains to be worked out.

Details: Luxembourg: Publications Office of the European Union, 2013. 46p.

Source: Internet Resource: Accessed April 5, 2013 at: http://ec.europa.eu/justice/anti-drugs/files/eu_market_summary_en.pdf

Year: 2013

Country: Europe

URL: http://ec.europa.eu/justice/anti-drugs/files/eu_market_summary_en.pdf

Shelf Number: 128295

Keywords:
Drug Abuse and Addiction
Drug Abuse and Crime
Drug Policies
Illicit Drug Markets (Europe)